Wavemaker job12/29/2022 ![]() ![]() If anything, the pandemic highlighted the need within the biotech community to embrace technology to help them run both efficient and robust clinical trials. ![]() It was selected as one of two Australian companies to pitch at BIO2022 in San Diego in June 2022.”ĬEO and founder of Evrima Charlotte Bradshaw said: “Most of our growth to date has been on the back of referrals and repeat business from our clients. The company has also made inroads in expanding to the US–a dominant market for clinical trials. “Operating during the COVID-19 pandemic, Evrima saw 306% growth in its annualised revenue and was recognised for it in last year’s Deloitte Fast 50 Awards. ![]() “The company has gone on to work with Avance Clinical, Top 5 pharmaceutical, and ASX-listed biotechnology companies, assisting with clinical trials for various therapeutics and devices. Similarly, by registering their study, sponsors and researchers can access qualified participants for their trial, and leverage operational data to help make informed decisions regarding the management of the trial,” notes Evrima. “Evrima’s platform allows patients and their doctors to easily register their interest for various clinical trials using digital phenotypes and workflow automation. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |